Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Scancell Holdings (SCLP) Share Price

Price 11.70p on 16-01-2026 at 19:40:08
Change -0.15p -1.27%
Buy 12.20p
Sell 11.20p
Last Trade: Buy 4,691.00 at 11.81p
Day's Volume: 473,904
Last Close: 11.70p
Open: 11.85p
ISIN: GB00B63D3314
Day's Range 11.70p - 11.85p
52wk Range: 7.25p - 12.25p
Market Capitalisation: £121.42m
VWAP: 12.01395p
Shares in Issue: 1.04b

Scancell Holdings (SCLP) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 4,691 11.81p Ordinary
16:06:14 - 16-Jan-26
Buy* 18,700 12.20p Ordinary
14:49:58 - 16-Jan-26
Buy* 2,000 12.05p Ordinary
14:44:59 - 16-Jan-26
Buy* 683 12.05p Ordinary
14:25:48 - 16-Jan-26
Buy* 59,775 12.05p Ordinary
13:59:38 - 16-Jan-26
Buy* 5,428 12.05p Ordinary
13:58:33 - 16-Jan-26
Buy* 5,000 12.0725p Ordinary
13:48:48 - 16-Jan-26
Buy* 38,791 11.81p Ordinary
13:19:35 - 16-Jan-26
Buy* 4,000 12.095p Ordinary
13:11:11 - 16-Jan-26
Buy* 16,535 12.095p Ordinary
12:42:28 - 16-Jan-26
See more Scancell Holdings trades

Scancell Holdings (SCLP) Share Price History

Time period:
to
Date Open High Low Close Volume
16th Jan 2026 (Fri) 11.85 11.85 11.70 11.70 473,904
15th Jan 2026 (Thu) 11.75 11.85 11.75 11.85 1,170,066
14th Jan 2026 (Wed) 11.75 11.75 11.75 11.75 766,488
13th Jan 2026 (Tue) 12.25 12.25 11.75 11.75 2,518,014
12th Jan 2026 (Mon) 11.25 12.25 11.75 12.25 3,539,873
9th Jan 2026 (Fri) 10.90 11.25 10.75 11.25 3,062,664
8th Jan 2026 (Thu) 10.00 10.75 10.00 10.75 1,761,982
7th Jan 2026 (Wed) 10.00 10.00 10.00 10.00 486,049
6th Jan 2026 (Tue) 10.10 10.10 9.90 10.00 4,772,136
5th Jan 2026 (Mon) 9.90 10.10 9.90 10.10 2,675,181
2nd Jan 2026 (Fri) 9.90 9.90 9.90 9.90 80,893
1st Jan 2026 (Thu) 9.90 9.90 9.90 9.90 0
31st Dec 2025 (Wed) 9.90 9.90 9.90 9.90 302,135
30th Dec 2025 (Tue) 9.75 9.90 9.75 9.90 619,718
29th Dec 2025 (Mon) 9.75 9.75 9.75 9.75 106,694
26th Dec 2025 (Fri) 9.75 9.75 9.75 9.75 0
25th Dec 2025 (Thu) 9.75 9.75 9.75 9.75 0
24th Dec 2025 (Wed) 9.75 9.75 9.75 9.75 157,764
23rd Dec 2025 (Tue) 9.80 9.85 9.75 9.75 249,610
22nd Dec 2025 (Mon) 10.00 9.90 9.90 9.90 4,184,605
19th Dec 2025 (Fri) 10.20 10.20 10.00 10.00 524,685
18th Dec 2025 (Thu) 10.20 10.20 10.20 10.20 412,313
17th Dec 2025 (Wed) 10.20 10.20 10.20 10.20 646,362
See more Scancell Holdings price history

Scancell Holdings (SCLP) Regulatory News

Date Source Headline
9th Dec 2025 7:00 am RNS Continued improvement in PFS with iSCIB1+
7th Nov 2025 7:00 am RNS Research Update
30th Oct 2025 3:30 pm RNS Result of AGM
3rd Oct 2025 7:00 am RNS Notice of AGM
16th Sep 2025 7:00 am RNS Director Dealing
11th Sep 2025 7:00 am RNS Final Results
4th Sep 2025 7:00 am RNS Notice of Results
8th Aug 2025 12:31 pm RNS Director Dealing
4th Aug 2025 10:23 am RNS Director/PDMR Shareholding
22nd Jul 2025 7:00 am RNS Strong Phase 2 data on iSCIB1+ in Melanoma
See more Scancell Holdings regulatory news

Scancell Holdings (SCLP) Share News

UK shareholder meetings calendar - next 7 days

23rd Oct 2025 14:28

Read More

TRADING UPDATES: Gfinity's Yentra partners with ESG Institute

17th Sep 2025 06:55

(Alliance News) - The following is a round-up of trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

Scancell Holdings notes "tough" macro-environment as loss widens

11th Sep 2025 12:06

(Alliance News) - Scancell Holdings PLC on Thursday said it has made "strong progress" over the last 18 months, but noted impacts from the "tough macroeconomic environment", as it posted a wider full-year loss. Read More

TRADING UPDATES: Scancell reports positive data from melanoma trial

23rd Jul 2025 16:47

(Alliance News) - The following is a round-up of updates and earnings by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

Scancell partners with NHS to fast-track melanoma vaccine trial

14th Apr 2025 14:02

(Alliance News) - Scancell Holdings PLC on Monday said it has partnered with the NHS Cancer Vaccine Launch Pad, to accelerate patient recruitment into the fourth cohort of its phase 2 scope study for a targeted melanoma vaccine. Read More

See more Scancell Holdings news
FTSE 100 Latest
Value10,235.29
Change-3.65

Login to your account

Forgot Password?

Not Registered